设计,合成和抗瘤活动的赛拉斯特 thiazole 衍生物与增强的共价结合能力
Siqi Zhang1, Maoshan Zhang1, Bing Zhang1
1State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
Bioorganic & medicinal chemistry letters
|March 16, 2026
概括
新的塞拉斯 (CEL) 提亚衍生物显示出增强的抗瘤潜力. 化合物28是一种强有力的衍生物,表现出显著的抗增殖活性,并在癌细胞中诱导了亡,这证明了进一步的癌症治疗研究.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 有机合成 有机合成
背景情况:
- 塞拉斯特 (CEL) 是一种天然产品,由于其子甲基 (QM) 部分,具有显著的抗瘤潜力.
- CEL的QM部分以共方式与囊二醇结合,有助于其抗癌活性.
- 提高CEL的共价结合能力是提高其抗瘤疗效的策略之一.
研究的目的:
- 设计和合成新型的塞拉斯特 thiazole 衍生物.
- 评估这些衍生物的抗增殖活性和共价结合能力.
- 为了研究最强大的衍生品的作用机制.
主要方法:
- 合成了30种塞拉斯特 thiazole 衍生物.
- 在人癌细胞系的体外抗增殖试验 (MCF-7,MDA-MB-231,A549,BGC-823).
- 药理学研究,包括用滴二醇 (DTT) 进行结合测定和细胞循环分析.
主要成果:
- 与CEL相比,大多数合成衍生品显示出增强的抗增殖活性.
- 化合物28显示对MDA-MB-231细胞的最大效应 (IC50 = 0.29 ± 0.02μM).
- 化合物28比CEL表现出比CEL更优越和更稳定的DTT结合,诱导了细胞亡,并导致G2/M细胞循环停止.
结论:
- 化合物28是一种有前途的塞拉斯特衍生物,具有增强的抗瘤特性.
- 化合物28的改进的共价结合能力有助于其强大的抗增殖作用.
- 化合物28需要进一步研究,因为它是癌症治疗的潜在候选者.
相关概念视频
Drug-Receptor Bonds
5.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
5.2K
Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Drugs that Destabilize Microtubules
4.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
63
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63


